mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.006 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.009 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.009 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |